[1]
“Impaired booster-induced SARS-CoV-2 antibody responses in rituximab-treated B-cell lymphoma patients despite peripheral B-cell recovery”, Radiol Oncol, vol. 60, no. 1, pp. 76–85, Mar. 2026, Accessed: Sep. 21, 2026. Available: https://www.radioloncol.com/index.php/ro/article/view/4845